ABSTRACT
Background In the 1960s, a United States (US) Senate Committee, the Kefauver Committee, found that India was among the highest priced nations in the world for pharmaceuticals.2 In 2007, however, Médecins sans Frontières, the international medical aid organization which operates in more than seventy countries, described India as the ‘pharmacy for the developing world’.
